All Stories

  1. Ecogenetics of antibiotic resistance in Listeria monocytogenes
  2. Interventions on Metabolism: Making Antibiotic-Susceptible Bacteria
  3. Antibiotic-Resistant Klebsiella pneumoniae and Escherichia coli High-Risk Clones and an IncFIIkMosaic Plasmid Hosting Tn1(blaTEM-4) in Isolates from 1990 to 2004
  4. Causes and interventions: need of a multiparametric analysis of microbial ecobiology
  5. Molecular Characterization and Genetic Diversity of ESBL-Producing Escherichia coli Colonizing the Migratory Franklin's Gulls ( Leucophaeus pipixcan ) in Antofagasta, North of Chile
  6. Streptococcus gallolyticus subsp. gallolyticus from Human and Animal Origins: Genetic Diversity, Antimicrobial Susceptibility, and Characterization of a Vancomycin-Resistant Calf Isolate Carrying avanA-Tn1546-Like Element
  7. Population Biology of Intestinal Enterococcus Isolates from Hospitalized and Nonhospitalized Individuals in Different Age Groups
  8. What is a resistance gene? Ranking risk in resistomes
  9. Public health evolutionary biology of antimicrobial resistance: priorities for intervention
  10. Widening the Spaces of Selection: Evolution along Sublethal Antimicrobial Gradients
  11. Impacto de los movimientos migratorios en la resistencia bacteriana a los antibióticos
  12. Proteomic analysis of the adaptation to warming in the Antarctic bacteria Shewanella frigidimarina
  13. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study
  14. Recombination Blurs Phylogenetic Groups Routine Assignment in Escherichia coli: Setting the Record Straight
  15. A model-guided analysis and perspective on the evolution and epidemiology of antibiotic resistance and its future
  16. Counteracting antibiotic resistance: breaking barriers among antibacterial strategies
  17. Modularization and Evolvability in Antibiotic Resistance
  18. Emergence and spread of antibiotic resistance: setting a parameter space
  19. Individual variability in finger‐to‐finger transmission efficiency of Enterococcus faecium clones
  20. New Microbes and New Infections
  21. Correction: Normal Mutation Rate Variants Arise in a Mutator (Mut S) Escherichia coli Population
  22. Normal Mutation Rate Variants Arise in a Mutator (Mut S) Escherichia coli Population
  23. Un ecosistema malalt: la lluita contra la resistència a antibiòtics des d’una perspectiva global
  24. Epigenetics, epistasis and epidemics
  25. Microevolutionary Events Involving Narrow Host Plasmids Influences Local Fixation of Vancomycin-Resistance in Enterococcus Populations
  26. Bloody coli: a Gene Cocktail in Escherichia coli O104:H4
  27. Detección de genes de virulencia en cepas de Enterococcus faecalis susceptibles y resistentes a aminoglucósidos
  28. Antibiotic resistance shaping multi-level population biology of bacteria
  29. Eukaryotic microorganisms in cold environments: examples from Pyrenean glaciers
  30. Mass spectrometry for direct identification of biosignatures and microorganisms in Earth analogs of Mars
  31. Biotechnological Applications of Cold-Adapted Bacteria
  32. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients
  33. Metagenomic epidemiology: a public health need for the control of antimicrobial resistance
  34. The microbiome as a human organ
  35. On the Shifting Balance: the Case of Staphylococcus aureus CC398
  36. Gel Electrophoresis of Proteins
  37. Intelligibility in microbial complex systems: Wittgenstein and the score of life
  38. Beyond serial passages: new methods for predicting the emergence of resistance to novel antibiotics
  39. Multilevel population genetics in antibiotic resistance
  40. The Evolution of Antibiotic Resistance
  41. List of Contributors
  42. Identification of in vivo HSP90-interacting proteins reveals modularity of HSP90 complexes is dependent on the environment in psychrophilic bacteria
  43. Prudent use of antimicrobial agents: Revisiting concepts and estimating perspectives in a global world
  44. Tuberculous Orchiepididymitis During 1978-2003 Period: Review of 34 Cases and Role of 16SrRNA Amplification
  45. Assessment of prevalence and changing epidemiology of extended-spectrum β-lactamase–producing Enterobacteriaceae fecal carriers using a chromogenic medium
  46. Public health microbiology, a challenge for Europe
  47. Polymorphic Mutation Frequencies of Clinical and Environmental Stenotrophomonas maltophilia Populations
  48. Evolutionary Trajectories of Beta-Lactamase CTX-M-1 Cluster Enzymes: Predicting Antibiotic Resistance
  49. Antibiotics and the Evolution of Antibiotic Resistance
  50. Ecology and evolution of antibiotic resistance
  51. Generational coexistence and ancestor's inhibition in bacterial populations
  52. In Vitro Susceptibilities of Aerobic and Facultatively Anaerobic Gram-Negative Bacilli Isolated from Patients with Intra-Abdominal Infections Worldwide: 2005 Results from Study for Monitoring Antimicrobial Resistance Trends (SMART)
  53. Predictions: evolutionary trajectories and planet medicine
  54. Colonización-infección bronquial por Staphylococcus aureus resistente a meticilina en pacientes con fibrosis quística
  55. Evolutionary Biology of Drug Resistance
  56. Environmental stress and evolvability in microbial systems
  57. The complexed structure and antimicrobial activity of a non-β-lactam inhibitor of AmpC β-lactamase
  58. De la enseñanza de los conocimientos teóricos en medicina
  59. Actividad comparativa de daptomicina frente a microorganismos grampositivos: programa SENTRY España (2002-2006)
  60. Actividad comparativa de daptomicina frente a microorganismos grampositivos: programa SENTRY España (2002-2006)
  61. Antibiotics and antibiotic resistance in water environments
  62. Detection of high-risk human papillomavirus by two molecular techniques: Hybrid capture and linear array
  63. Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 β-lactamase–producing Klebsiella pneumoniae epidemic clone
  64. Evaluation of Cobas Ampliprep Automated Nucleic Acid Extraction for Genotyping Human Papillomavirus (HPV) by the Roche linear array HPV Test
  65. The Neglected Intrinsic Resistome of Bacterial Pathogens
  66. Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15
  67. The evolution of contact-dependent inhibition in non-growing populations of Escherichia coli
  68. The role of apoptosis in Listeria monocytogenes neural infection: Listeriolysin O interaction with neuroblastoma Neuro-2a cells
  69. Predicting antibiotic resistance
  70. Evolutionary Biology of Bacterial and Fungal Pathogens
  71. Mutation rate is reduced by increased dosage of mutL gene in Escherichia coli K-12
  72. Los complejos clonales de alto riesgo CC2 y CC9 están ampliamente representados en cepas hospitalarias de Enterococcus faecalis aisladas en España
  73. Recomendaciones para la selección de antimicrobianos en el estudio de la sensibilidad in vitro con sistemas automáticos y semiautomáticos
  74. Detección y genotipado del virus del papiloma humano de alto riesgo en muestras de lesiones cervicales
  75. In Vitro Susceptibilities of Escherichia coli Isolated from Patients with Intra-Abdominal Infections Worldwide in 2002–2004: Results from SMART (Study for Monitoring Antimicrobial Resistance Trends)
  76. Antimicrobials
  77. Evaluation of 4 swab transport systems for the recovery of ATCC and clinical strains with characterized resistance mechanisms
  78. In vitro plasmid-encoded resistance to quinolones
  79. The making of The Genoma Music
  80. Increased Mutation Frequencies in Escherichia coli Isolates Harboring Extended-Spectrum β-Lactamases
  81. Demographic analysis of antimicrobial resistance among Streptococcus pneumoniae: worldwide results from PROTEKT 1999–2000
  82. Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex
  83. Evolución del patrón de sensibilidad de aislados de Escherichia coli en urocultivos procedentes del medio hospitalario y extrahospitalario
  84. Antimicrobial-resistant Invasive Escherichia coli , Spain
  85. Estudio seroepidemiológico de la hepatitis A en la comunidad de Madrid durante el año 2002
  86. Fosfomycin and Rifampin Disk Diffusion Tests for Detection of Escherichia coli Mutator Strains
  87. Increase of resistance to macrolides in invasive Streptococcus pneumoniae in Spain (2000-2001)
  88. Polymorphic Mutation Frequencies in Escherichia coli: Emergence of Weak Mutators in Clinical Isolates
  89. From pieces to patterns: evolutionary engineering in bacterial pathogens
  90. Estudio seroepidemiológico de la hepatitis A en la comunidad de Madrid durante el año 2002
  91. Differential interactions within the Caenorhabditis elegans—Pseudomonas aeruginosa pathogenesis model
  92. Multi-resistant Gram-negative bacilli: from epidemics to endemics
  93. Multi-resistant Gram-negative bacilli
  94. Actividad in vitro comparativa de garenoxacino (BMS-284756). Programa SENTRY España (1999-2000)
  95. Haemophilus influenzae bla ROB-1 Mutations in Hypermutagenic ΔampC Escherichia coli Conferring Resistance to Cefotaxime and β-Lactamase Inhibitors and Increased Susceptibility to Cefaclor
  96. Multi-resistant Gram-negative bacilli: from epidemics to endemics
  97. Frequency of Mutation to Rifampin Resistance in Streptococcus pneumoniae Clinical Strains: hexA and hexB Polymorphisms Do Not Account for Hypermutation
  98. Frequency of Mutation to Rifampin Resistance in Streptococcus pneumoniae Clinical Strains: hexA and hexB Polymorphisms Do Not Account for Hypermutation
  99. Antimicrobial susceptibility profile of molecular typed cystic fibrosisStenotrophomonas maltophiliaisolates and differences with noncystic fibrosis isolates
  100. Evaluación del sistema ROBOBACT® para el procesamiento automático de coprocultivos
  101. Resistencia a antibióticos en 622 Streptococcus pneumoniae aislados de líquido cefalorraquídeo y sangre en 33 hospitales españoles de la Red Europea de Vigilancia de Resistencia a Antibióticos (2000)
  102. Resistencia a antibióticos en 622 Streptococcus pneumoniae aislados de líquido cefalorraquídeo y sangre en 33 hospitales españoles de la Red Europea de Vigilancia de Resistencia a Antibióticos (2000)
  103. Antibiotic consumption and resistance selection in Streptococcus pneumoniae
  104. Interactions among Strategies Associated with Bacterial Infection: Pathogenicity, Epidemicity, and Antibiotic Resistance
  105. Allodemics
  106. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants
  107. Very Low Cefotaxime Concentrations Select for Hypermutable Streptococcus pneumoniae Populations
  108. Resistencia a antibióticos: ¿qué hacer ahora?
  109. Resistencia a antibióticos en Staphylococcus aureus aislados de sangre en 31 hospitales españoles de la Red Europea de Vigilancia de Resistencia a Antibióticos (2000)
  110. Validation of the VITEK2 and the advance expert system with a collection of enterobacteriaceae harboring extended spectrum or inhibitor resistant β-lactamases
  111. Performance of the VITEK2 system for identification and susceptibility testing of routine Enterobacteriaceae clinical isolates
  112. Low-level antibacterial resistance: a gateway to clinical resistance
  113. Antibiotic clinical trials revisited
  114. Mutation Frequencies and Antibiotic Resistance
  115. A multidrug efflux transporter in Listeria monocytogenes
  116. Activity of garlic extracts on Helicobacter pylori growth
  117. Vancomycin-resistant enterococci isolated from animals and food
  118. Roundtable discussion: Cephalosporins in the 1990s and beyond
  119. Perspectives of oral cephalosporins in upper respiratory tract infections
  120. MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care unit patient surveillance cultures
  121. Hepatitis E Virus: Relevance in Blood Donors and Risk Groups
  122. In vitro selective concentrations of cefepime and ceftazidime for AmpC β-lactamase hyperproducer Enterobacter cloacae variants
  123. Hepatitis E Virus: Relevance in Blood Donors and Other Risk Groups
  124. Structure-Based Enhancement of Boronic Acid-Based Inhibitors of AmpC β-Lactamase
  125. In vitro selective concentrations of cefepime and ceftazidime for AmpC β-lactamase hyperproducer Enterobacter cloacae variants
  126. Aerosolized vancomycin for the treatment of methicillin‐resistant Staphylococcus aureus infection in cystic fibrosis
  127. Aerosolized vancomycin for the treatment of methicillin-resistantStaphylococcus aureus infection in cystic fibrosis
  128. Antibiotic‐Selective Environments
  129. An extended-spectrum AmpC-type β-lactamase obtained by in vitro antibiotic selection
  130. Failure to detect Helicobacter pylori in vaginal secretions
  131. Dual infection due to Aeromonas hydrophila and Aeromonas sobria in a woman after a home accident
  132. Epidemiology and mechanisms of resistance among respiratory tract pathogens
  133. Antimicrobial Susceptibility Profiles of Oropharyngeal Viridans Group Streptococci Isolates from Cystic Fibrosis and Non-Cystic Fibrosis Patients
  134. Evolution of antibiotic resistance
  135. Lung colonization withEnterobacteriaceae producing extended-spectrum β-lactamases in cystic fibrosis patients
  136. Challenges: Selective compartments for resistant microorganisms in antibiotic gradients
  137. Gram-positive resistance: challenge for the development of new antibiotics
  138. The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci
  139. Inducible β-lactamase-mediated resistance to third-generation cephalosporins
  140. Yersinia enterocolitica Infection in a Patient With Posttraumatic Paravertebral Hematoma
  141. Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media
  142. Epidemiology and management of penicillin-resistant pneumococci
  143. β-Lactam stability in frozen microdilution PASCO MIC panels using strains with known resistance mechanisms as biosensors
  144. Bacteriologic diagnosis of respiratory tract infection
  145. hns mutant unveils the presence of a latent haemolytic activity in Escherichia coli K-12
  146. The General Approach to Cystic Fibrosis Pulmonary Infection in Spain
  147. Spread and evolution of natural plasmids harboring transposon Tn5
  148. Modulation of DNA topology by flaR, a new gene from Listeria monocytogenes
  149. Resistance of Veillonella to Hydrosoluble Pristinamycins: A Possible Outer Membrane Barrier Effect
  150. Pneumococcal Resistance to β-Lactam Antibiotics: A Global Geographic Overview
  151. Improved method of determining the susceptibility of Candida albicans to fluconazole
  152. Antibiotic resistance of microorganisms involved in ear, nose and throat infections
  153. Antibacterial activity of clavulanate and tazobactam on Peptostreptococcus spp.
  154. Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.
  155. Galenical formulations of amoxicillin/clavulanate and eradication of Helicobacter pylori in peptic ulcer patients
  156. The E-Test as an epidemiologic tool
  157. Antibiotic sensitivity of ribosomes from wild-type and clindamycin resistant Bacteroides vulgatus strains
  158. Hanseniaspora guilliermondii Fungemia in an intravenous drug addict with aids
  159. From accuracy towards truth: the BSAC Working Party's guide to sensitivity testing
  160. Mechanisms of iron acquisition and bacterial virulence
  161. Aerobactin production and plasmid distribution in Escherichia coli clinical isolates
  162. A protoplast transformation system for Listeria sp
  163. Discussion
  164. Induction of the SOS response by new 4-quinolones
  165. Multifactorial determination of systemic invasivity in Escherichia coli
  166. Cloning and expression of the Listeria monocytogenes haemolysin in Escherichia coli
  167. The microcins
  168. The microcins
  169. Epidemiology of clindamycin resistance in the Bacteroides fragilis group
  170. Microcin 15n: a second antibiotic from Escherichia coli LP15.
  171. Plasmids in Listeria
  172. Fosfomycin and Plasmidic Resistance
  173. A new family of low molecular weight antibiotics from enterobacteria
  174. Topical Debates Evaluation of Risks and Benefits of Consumption of Antibiotics: From Individual to Public Health